MedTrace Logo

Zenith® Dissection Endovascular System in the Treatment of Patients With Aortic Dissections

NCT02464943 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS

Last updated 2020-01-18

No results posted yet for this study

Summary

The Zenith® Dissection extended study is to collect confirmatory safety and effectiveness data on the Zenith® Dissection Endovascular System in the treatment of acute, complicate Type B aortic dissection.

Conditions

  • Aortic Dissection

Interventions

DEVICE

Endovascular Treatment (Zenith)

Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta.

Sponsors & Collaborators

  • Cook Research Incorporated

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02464943 on ClinicalTrials.gov